CR10794A - Composiciones de fenilalquilamino-carbamato - Google Patents
Composiciones de fenilalquilamino-carbamatoInfo
- Publication number
- CR10794A CR10794A CR10794A CR10794A CR10794A CR 10794 A CR10794 A CR 10794A CR 10794 A CR10794 A CR 10794A CR 10794 A CR10794 A CR 10794A CR 10794 A CR10794 A CR 10794A
- Authority
- CR
- Costa Rica
- Prior art keywords
- phenylalquilamine
- carbamate
- carbamate compositions
- compositions
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion se refiere a una composicion de un compuesto de fenilquilamino-carbamoto con estabilidad mejorada, en donde la composicion comprende un compuesto de fenialquilamino-carbamato en mezcla con una cantidad efectiva de uno o mas excipientes, en donde por lo menos un excipiente es fosfato dibasico de calcio dihidratado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82934206P | 2006-10-13 | 2006-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10794A true CR10794A (es) | 2009-09-29 |
Family
ID=39111348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10794A CR10794A (es) | 2006-10-13 | 2009-05-13 | Composiciones de fenilalquilamino-carbamato |
Country Status (19)
Country | Link |
---|---|
US (1) | US20080090902A1 (es) |
EP (1) | EP2079449A2 (es) |
JP (1) | JP2010506845A (es) |
KR (1) | KR20090082213A (es) |
CN (1) | CN101557804A (es) |
AU (1) | AU2007313017A1 (es) |
BR (1) | BRPI0719275A2 (es) |
CA (1) | CA2673487A1 (es) |
CO (1) | CO6180500A2 (es) |
CR (1) | CR10794A (es) |
EA (1) | EA200970377A1 (es) |
GT (1) | GT200900082A (es) |
IL (1) | IL198145A0 (es) |
MX (1) | MX2009003926A (es) |
NI (1) | NI200900053A (es) |
NO (1) | NO20091530L (es) |
SV (1) | SV2009003221A (es) |
WO (1) | WO2008048801A2 (es) |
ZA (1) | ZA200903283B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006254899B2 (en) | 2005-06-08 | 2011-11-24 | Sk Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
US8741950B2 (en) | 2009-06-22 | 2014-06-03 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating or preventing fatigue |
MX2012005258A (es) | 2009-11-06 | 2012-06-19 | Sk Biopharmaceuticals Co Ltd | El uso de un compuesto de carbamoilo para el tratamiento del trastorno de deficit de atencion/hiperactividad. |
AU2010316172B2 (en) * | 2009-11-06 | 2015-11-12 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating fibromyalgia syndrome |
US9610274B2 (en) * | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
US8623913B2 (en) * | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
KR102014615B1 (ko) | 2013-03-12 | 2019-08-27 | (주)바이오팜솔루션즈 | 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물 |
CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
DK2968208T3 (da) | 2013-03-13 | 2022-08-22 | Jazz Pharmaceuticals Ireland Ltd | Behandling af kataplexi |
CN110638804A (zh) | 2013-07-18 | 2020-01-03 | 爵士制药国际Iii有限公司 | 治疗肥胖 |
US10195151B2 (en) * | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
KR20200016889A (ko) | 2017-06-02 | 2020-02-17 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 과다 졸림증을 치료하기 위한 방법 및 조성물 |
CN110037995B (zh) * | 2019-04-17 | 2021-07-06 | 石家庄龙泽制药股份有限公司 | 一种稳定的盐酸帕罗西汀片剂及其制备方法 |
US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
IT202000013855A1 (it) | 2020-06-10 | 2021-12-10 | Flamma Spa | Un processo per la purificazione del (r)-2-ammino-3-fenilpropil carbammato |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3342687A (en) * | 1964-06-25 | 1967-09-19 | Colgate Palmolive Co | Oral preparation |
US3420817A (en) * | 1966-12-06 | 1969-01-07 | Hoffmann La Roche | 4,1,5-benzoxadiazocin-2-ons and processes for preparing same |
US6372438B1 (en) * | 1988-02-02 | 2002-04-16 | The Regents Of The University Of California | Human platelet-derived growth factor receptors |
KR100197892B1 (ko) * | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
KR0173862B1 (ko) * | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
US5756817C1 (en) * | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
KR0173863B1 (ko) * | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
DE69618663T2 (de) * | 1996-10-10 | 2002-08-14 | Sk Corp | O-carbamoyl-phenylalaninol-zusammensetzungen und ihre pharmazeutisch anwendbaren salzen |
US20020151543A1 (en) * | 1998-05-28 | 2002-10-17 | Sepracor Inc. | Compositions and methods employing R (-) fluoxetine and other active ingredients |
CA2418038A1 (en) * | 2000-08-28 | 2002-03-07 | Synthon B.V. | Paroxetine compositions and processes for making the same |
-
2007
- 2007-10-08 EP EP07843957A patent/EP2079449A2/en not_active Withdrawn
- 2007-10-08 US US11/868,555 patent/US20080090902A1/en not_active Abandoned
- 2007-10-08 BR BRPI0719275-4A2A patent/BRPI0719275A2/pt not_active IP Right Cessation
- 2007-10-08 MX MX2009003926A patent/MX2009003926A/es not_active Application Discontinuation
- 2007-10-08 CA CA002673487A patent/CA2673487A1/en not_active Abandoned
- 2007-10-08 CN CNA2007800458003A patent/CN101557804A/zh active Pending
- 2007-10-08 EA EA200970377A patent/EA200970377A1/ru unknown
- 2007-10-08 AU AU2007313017A patent/AU2007313017A1/en not_active Abandoned
- 2007-10-08 WO PCT/US2007/080675 patent/WO2008048801A2/en active Application Filing
- 2007-10-08 JP JP2009532514A patent/JP2010506845A/ja active Pending
- 2007-10-08 KR KR1020097009750A patent/KR20090082213A/ko not_active Application Discontinuation
-
2009
- 2009-04-13 NI NI200900053A patent/NI200900053A/es unknown
- 2009-04-13 GT GT200900082A patent/GT200900082A/es unknown
- 2009-04-14 SV SV2009003221A patent/SV2009003221A/es unknown
- 2009-04-14 CO CO09037414A patent/CO6180500A2/es not_active Application Discontinuation
- 2009-04-16 IL IL198145A patent/IL198145A0/en unknown
- 2009-04-17 NO NO20091530A patent/NO20091530L/no not_active Application Discontinuation
- 2009-05-12 ZA ZA200903283A patent/ZA200903283B/xx unknown
- 2009-05-13 CR CR10794A patent/CR10794A/es unknown
Also Published As
Publication number | Publication date |
---|---|
GT200900082A (es) | 2010-02-24 |
SV2009003221A (es) | 2010-04-15 |
EA200970377A1 (ru) | 2009-10-30 |
NO20091530L (no) | 2009-07-06 |
US20080090902A1 (en) | 2008-04-17 |
CO6180500A2 (es) | 2010-07-19 |
EP2079449A2 (en) | 2009-07-22 |
ZA200903283B (en) | 2010-07-28 |
NI200900053A (es) | 2010-02-01 |
WO2008048801A3 (en) | 2008-06-05 |
MX2009003926A (es) | 2009-06-26 |
IL198145A0 (en) | 2009-12-24 |
JP2010506845A (ja) | 2010-03-04 |
BRPI0719275A2 (pt) | 2014-04-29 |
CA2673487A1 (en) | 2008-04-24 |
AU2007313017A1 (en) | 2008-04-24 |
WO2008048801A2 (en) | 2008-04-24 |
KR20090082213A (ko) | 2009-07-29 |
CN101557804A (zh) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR10794A (es) | Composiciones de fenilalquilamino-carbamato | |
EA200970378A1 (ru) | Композиции фенилалкилкарбамата | |
TW200621313A (en) | Pharmaceutical compositions | |
EA200701462A1 (ru) | Распадающаяся при пероральном приёме композиция оланзапина или донепезила | |
GT200500102A (es) | Compuestos de aril-o-heteroarilamida ortosustituidos | |
HN2003000417A (es) | Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico | |
AR070498A1 (es) | Composicion detergente que comprende lipasa | |
ATE535597T1 (de) | Konzentrierte aktive weichspülerzusammensetzungen | |
PA8671301A1 (es) | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricación y utilización | |
BR122013025375B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
HN2012001162A (es) | Triazolopiridinas | |
ATE543521T1 (de) | Calciumphosphat-zement | |
BRPI0917017B8 (pt) | inibidores de pirrol de s-nitrosoglutationa redutase como agentes terapêuticos | |
BRPI0512374A (pt) | agentes auxiliares de moagem de cimento | |
HN2008001667A (es) | Antagonistas de los receptores cgrp espirociclicos sustituidos | |
CR11137A (es) | Valvulas prosteticas de corazon | |
GT200500130A (es) | Forma cristalina alfa del ranelato de estroncio, procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
PA8625201A1 (es) | Composiciones de peróxido estabilizadas | |
CR20110209A (es) | Composición farmacéutica sólida | |
UY30778A1 (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona | |
CR8111A (es) | Derivados sustituidos del pirrol | |
BRPI0810399B8 (pt) | composto, composição farmacêutica que o contém e uso do mesmo | |
EA201101118A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
ZA200905690B (en) | Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectant | |
ECSP088374A (es) | Formulacion de aerosol para inhalacion |